Forbes contributors publish independent expert analyses and insights. I write about the big picture of artificial intelligence. We stand at the cusp of a massive technology paradigm shift that ...

What are brain-computer interfaces? Brain-computer interfaces (BCIs) are devices that allow for the action or control of an external device from brain signals. These technologies have a broad range of ...

Forbes contributors publish independent expert analyses and insights. Jason Alan Snyder is a technologist covering AI and innovation. New research shows brain-computer interfaces can decode inner ...

The evolution of information access and interaction has been a transformative technological and human journey, from Gutenberg's printing press to Google's search engine. As we stand at the beginning ...

Neurosurgeon and Engineer Dr. Ben Rapoport, co-founder of Precision Neuroscience, joins WIRED to answer the internet's burning questions about the emerging technology of brain implants and ...

OpenAI has backed Merge Labs, a brain-computer interface startup co-founded by Sam Altman, as part of a $250 million seed round focused on non-invasive BCI technology.

When someone loses the ability to speak because of a neurological condition like ALS, the impact goes far beyond words. It touches every part of daily life, from sharing a joke with family to simply ...

Every four years at the Cybathlon, teams of researchers and technology “pilots” compete to see whose brain-computer interface holds the most promise. Owen Collumb, a Cybathlon race pilot who has been ...

June 2 (UPI) --Paradromics, a competitor of Neuralink, announced Monday it safely implanted a brain-computer interface into a human patient and recorded neural activity, before removing it 10 minutes ...

The brain-computer interface developer Synchron has shown that its minimally invasive device can help connect a patient with an iPad, allowing them to control the device entirely by thought using ...

Second implantation at Harborview Medical Center in Seattle marks continued progress in the FDA-approved study informed by promising results from the first participantFREIBURG, Germany, Feb. 10, 2026 ...